Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Maralixibat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 245,756Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mirum's Livmarli Now FDA Approved in Tablet Formulation
    Mirum's Livmarli Now FDA Approved in Tablet Formulation

    14 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250414769095/en/Mirums-LIVMARLI-Now-FDA-Approved-in-Tablet-Formulation

    BUSINESSWIRE
    14 Apr 2025
    Share Share
    Livmarli Now Approved in Japan for ALGS and PFIC
    Livmarli Now Approved in Japan for ALGS and PFIC

    27 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250327866446/en/LIVMARLI-Now-Approved-in-Japan-for-ALGS-and-PFIC

    BUSINESSWIRE
    27 Mar 2025
    Share Share
    Abacus & Mirum Partner To Commercialize LIVMARLI In Nordic
    Abacus & Mirum Partner To Commercialize LIVMARLI In Nordic

    10 Sep 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-09-10/abacus-mirum-partner-for-the-commercialization-of-livmarli-in-nordic-markets/?widget=listSection

    CONTRACT PHARMA
    10 Sep 2024
    Share Share
    Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
    Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older

    25 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240725047219/en

    BUSINESSWIRE
    25 Jul 2024
    Share Share
    Mirum's LIVMARLI Long-Term ALGS, PFIC Data At EASL
    Mirum's LIVMARLI Long-Term ALGS, PFIC Data At EASL

    06 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240606079628/en

    BUSINESSWIRE
    06 Jun 2024
    Share Share
    Mirum Pharma announces positive CHMP opinion for Livmarli oral solution
    Mirum Pharma announces positive CHMP opinion for Livmarli oral solution

    03 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169533&sid=2

    PHARMABIZ
    03 Jun 2024
    Share Share